mesalamine has been researched along with Cecal Diseases in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Cecal Diseases: Pathological developments in the CECUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Furthermore, the ulcer has since maintained the scar stage despite successfully weaning the patient from PSL." | 1.48 | Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. ( Hirayama, T; Honda, A; Ikegami, T; Iwamoto, J; Konishi, N; Matsuzaki, Y; Monma, T; Murakami, M; Ueda, H; Yara, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, J | 1 |
| Murakami, M | 1 |
| Konishi, N | 1 |
| Monma, T | 1 |
| Ueda, H | 1 |
| Yara, S | 1 |
| Hirayama, T | 1 |
| Ikegami, T | 1 |
| Honda, A | 1 |
| Matsuzaki, Y | 1 |
| Ono, M | 1 |
| Murakami, K | 1 |
| Oda, M | 1 |
| Miyajima, H | 1 |
| Watanabe, K | 1 |
| Sato, R | 1 |
| Nasu, M | 1 |
| Kashima, K | 1 |
1 review available for mesalamine and Cecal Diseases
| Article | Year |
|---|---|
[A case of simple ulcer with ulcerative colitis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Cecal Diseases; Colit | 2005 |
1 other study available for mesalamine and Cecal Diseases
| Article | Year |
|---|---|
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Cecal Diseases; Clarithromycin; Drug Th | 2018 |